Skip to content

Oxytocin's Effects on Face Attentional Processing

The Modulatory Effect of Oxytocin on Attentional Processing of Emotional Faces

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04413786
Enrollment
60
Registered
2020-06-04
Start date
2019-10-14
Completion date
2021-12-26
Last updated
2022-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

oxytocin, emotional faces, attention, N2pc

Brief summary

To investigate whether intranasal oxytocin (24IU) treatment has a regulatory effect on attentional processing of emotional faces.

Detailed description

In a placebo-controlled double-blind between-subject design experiment, investigators plan to investigate the effect of oxytocin treatment on attentional processing of emotional faces. Subjects complete questionnaires in Chinese versions before treatment administration, including the Beck Depression Inventory, Autism Spectrum Quotient , Trait Anxiety Inventory, Toronto Alexithymia Scale, Multidimentional Assessment of Interoceptive Awareness. This experiment consists of two tasks including Emotional Face Cue-target Task and Visual Search Task. In the first task, subjects need to make a response to judge the position of target after a cue-target is presented. In the second task, subjects are asked to search the target U or inverted U placed on the nose of emotional/neutral faces and make an choices based on their oorientation. During these phases, subjects' response accuracy, response time and electrophysiological activity (ERP) are recorded.

Interventions

intranasal administration of oxytocin (24IU)

DRUGplacebo treatment

intranasal administration of placebo (24IU)

Sponsors

University of Electronic Science and Technology of China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects without past or current psychiatric or neurological disorders.

Exclusion criteria

* history of head injury * medical or psychiatric illness

Design outcomes

Primary

MeasureTime frameDescription
Response time in reponse to different emotional face targets.1 hourResponse time in discriminating which side (left or right) the emotional face target appear.
N2pc1 hourN2pc is an enhanced negative event-related potential typically elicited at posterior electrodes (e.g., PO7 and PO8) contralateral to the target presented among distractors between 180 and 300 ms after the onset of stimuli. display.

Secondary

MeasureTime frameDescription
Response accuracy in response to different emotional face targets.1 hourResponse accuracy is caculated by the precentage of correct responses among the total responses in discriminating the position (left or right side) of different face conditions.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026